Image

Metabolic Cost of Walking With Passive vs. Powered Prosthetic Knees Among Persons With Limb Loss

Metabolic Cost of Walking With Passive vs. Powered Prosthetic Knees Among Persons With Limb Loss

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

The purpose of this industry-initiated research study is to test that a powered microprocessor controlled knee improves metabolic function during walking in level and sloped conditions as compared to the subject's physician prescribed prosthesis.

Description

The Procedures include:

Initial Visit:

  1. Informed consent
  2. HIPAA authorization
  3. Determine/verify ambulation potential
  4. Take and record body measurements (height, weight, circumferences)
  5. Activities-Specific Balance Confidence (ABC) scale
  6. L.A.S.A.R. Posture alignment assessment with RxPx

Second Visit

  1. Fit with heartrate monitor and metabolic analyzer mask
  2. Treadmill Test (level-ground) with RxPx
  3. Rest
  4. Treadmill Test (incline) with RxPx
  5. Fit subject with PMPK
  6. L.A.S.A.R. Posture alignment assessment with PMPK
  7. Subject uses PMPK for one week as their primary prosthesis

Third Visit (1 week later)

  1. Fit with heartrate monitor and metabolic analyzer mask
  2. Treadmill Test (level-ground) with PMPK
  3. Rest
  4. Treadmill Test (incline) with PMPK
  5. Activities-Specific Balance Confidence (ABC) scale
  6. Return PMPK and refit of RxPx
  7. Verify alignment with L.A.S.A.R. Posture alignment
  8. Check that all fasteners are secure

Eligibility

Inclusion Criteria:

  • Males and Females with unilateral knee disarticulation or transfemoral (KD/TF) amputation.
  • a body mass greater than 49Kg and less than 117Kg
  • 18-75 years of age
  • Have an ambulation potential of K3 or K4
  • Use a prosthesis daily for walking or sports activities
  • No less than six months of experience with a prosthesis
  • No socket issues or changes in the last six weeks
  • No residual limb pain affecting functional ability.

Exclusion Criteria:

  • Cannot walk at different speeds (MCFL K0-K2)
  • Limb-loss below the knee or through the hip
  • More than one amputation.
  • Uses an assistive device for walking
  • Uncontrolled edema in leg compartments
  • Compromised skin of the residual limb or contralateral foot
  • Are 180 days or less post-amputation
  • Pregnant (self-reported)

Study details
    Transfemoral Amputation

NCT05831696

Loma Linda University

13 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.